Table of Contents
Chapter 1. Global Thin Film Drug Manufacturing Market Executive Summary
1.1. Global Thin Film Drug Manufacturing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Disease Indication
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Thin Film Drug Manufacturing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Thin Film Drug Manufacturing Market Dynamics
3.1. Market Drivers
3.1.1. Advancements in Drug Delivery Technologies
3.1.2. Increase in Geriatric Population
3.1.3. Rising Investments in Drug Delivery Technologies
3.2. Market Challenges
3.2.1. High Cost of Development and Manufacturing
3.2.2. Regulatory Challenges
3.3. Market Opportunities
3.3.1. Integration of Nanotechnology
3.3.2. Growth in Personalized Medicine
Chapter 4. Global Thin Film Drug Manufacturing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Thin Film Drug Manufacturing Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Thin Film Drug Manufacturing Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Oral Thin Film
5.2.2. Sublingual Film
5.2.3. Fully Dissolving Dental/Buccal Film
5.2.4. Transdermal Thin Film
5.2.5. Others (Ocular Thin Film, etc.)
Chapter 6. Global Thin Film Drug Manufacturing Market Size & Forecasts by Disease Indication 2022-2032
6.1. Segment Dashboard
6.2. Global Thin Film Drug Manufacturing Market: Disease Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Schizophrenia
6.2.2. Migraine
6.2.3. Opioid Dependence
6.2.4. Nausea & Vomiting
6.2.5. Others
Chapter 7. Global Thin Film Drug Manufacturing Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Thin Film Drug Manufacturing Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Drug Stores
7.2.3. Retail Pharmacies
7.2.4. E-commerce
Chapter 8. Global Thin Film Drug Manufacturing Market Size & Forecasts by Region 2022-2032
8.1. North America Thin Film Drug Manufacturing Market
8.1.1. U.S. Thin Film Drug Manufacturing Market
8.1.1.1. Product breakdown size & forecasts, 2022-2032
8.1.1.2. Disease Indication breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Thin Film Drug Manufacturing Market
8.2. Europe Thin Film Drug Manufacturing Market
8.2.1. U.K. Thin Film Drug Manufacturing Market
8.2.2. Germany Thin Film Drug Manufacturing Market
8.2.3. France Thin Film Drug Manufacturing Market
8.2.4. Spain Thin Film Drug Manufacturing Market
8.2.5. Italy Thin Film Drug Manufacturing Market
8.2.6. Rest of Europe Thin Film Drug Manufacturing Market
8.3. Asia-Pacific Thin Film Drug Manufacturing Market
8.3.1. China Thin Film Drug Manufacturing Market
8.3.2. India Thin Film Drug Manufacturing Market
8.3.3. Japan Thin Film Drug Manufacturing Market
8.3.4. Australia & New Zealand Thin Film Drug Manufacturing Market
8.3.5. Rest of Asia Pacific Thin Film Drug Manufacturing Market
8.4. Latin America Thin Film Drug Manufacturing Market
8.4.1. Brazil Thin Film Drug Manufacturing Market
8.4.2. Mexico Thin Film Drug Manufacturing Market
8.4.3. Rest of Latin America Thin Film Drug Manufacturing Market
8.5. Middle East & Africa Thin Film Drug Manufacturing Market
8.5.1. Saudi Arabia Thin Film Drug Manufacturing Market
8.5.3. South Africa Thin Film Drug Manufacturing Market
8.5.4. Rest of Middle East & Africa Thin Film Drug Manufacturing Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pfizer, Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Novartis AG
9.3.3. Wolters Kluwer
9.3.4. Solvay
9.3.5. AbbVie
9.3.6. Sumitomo Pharma Co., Ltd
9.3.7. IntelGenx Corp.
9.3.8. NAL Pharma
9.3.9. ZIM Laboratories Limited
9.3.10. Indivior PLC
9.3.11. MonoSol
9.3.12. GSK (GlaxoSmithKline plc)
9.3.13. Cure Pharmaceutical Holding Corp.
9.3.14. Sumitomo Dainippon Pharma Co., Ltd.
9.3.15. Allergan plc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes